Development of a high-throughput three-dimensional h & e platform for the characterization of breast cancer biopsies
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA228878
- Recipient
-
Visikol Inc. UEI E92DHV41MJE3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $280,000
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Place of performance
- North Brunswick Township, NJ 08902, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $55,000 | |
| Original award | $225,000 |
Quick answers
Who received award R43CA228878?
R43CA228878 was awarded to Visikol Inc. by National Cancer Institute (National Institutes of Health) on May 1, 2018.
How much is award R43CA228878 worth?
$280,000 has been obligated on R43CA228878.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award